Clinical Trial Update: A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China

View source ↗

Summary

This is a post-approval, single-arm clinical trial evaluating the SYNERGY Stent System in China. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• SYNERGY Stent System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Cardiovascular Diseases | Status: ACTIVE_NOT_RECRUITING